GLP-1 Weight Loss in New Mexico: Obesity Data & Access
The short answer
In New Mexico, 34.5% of adults have obesity (2024 CDC data), which is higher than the national rate of 33.1%. GLP-1 medications are one option a licensed provider may consider for weight management. Whether New Mexico Medicaid helps pay for them depends on current state rules, and for most people without coverage, a cash-pay telehealth program is the practical path. Here is the data and what your options look like.
Obesity and metabolic health in New Mexico
Adults with obesity (2024)
34.5%
Obesity rank of 51 (1 = highest)
#24
No leisure-time physical activity (2024)
21.7%
Adult obesity prevalence in New Mexico is 34.5%, compared with 33.1% nationally (2024). That places New Mexico the 24th highest of the 51 states and DC.
On physical activity, 21.7% of adults in New Mexico report no leisure-time physical activity, versus 22.5% nationally. Activity level is one of several factors a provider weighs alongside weight history and overall health.
| Measure | New Mexico | National |
|---|---|---|
| Adult obesity (2024) | 34.5% | 33.1% |
| No leisure-time physical activity (2024) | 21.7% | 22.5% |
Source: CDC Nutrition, Physical Activity, and Obesity, Behavioral Risk Factor Surveillance System, 2024 release. Figures reflect self-reported height and weight. Full sources and methodology are listed at the bottom of this page.
How New Mexico compares to other states
New Mexico ranks 24th of 51 states and DC for adult obesity. See how nearby-ranked states compare:
- Missouri obesity and GLP-1 access – 34.6% adult obesity (rank 22)
- North Carolina obesity and GLP-1 access – 34.5% adult obesity (rank 23)
- Pennsylvania obesity and GLP-1 access – 34.2% adult obesity (rank 25)
- Nevada obesity and GLP-1 access – 34.2% adult obesity (rank 26)
Or compare every state in one table.
Does New Mexico Medicaid cover GLP-1 medications for weight loss?
Based on available information, New Mexico Medicaid generally does not cover GLP-1 medications prescribed specifically for weight loss. Coverage rules change frequently, vary by plan, and almost always require prior authorization when weight-management GLP-1s are covered at all. Confirm your current benefits directly with New Mexico Medicaid or your plan administrator before making any decisions.
Nationally, obesity-drug coverage in Medicaid remains limited: only 13 state Medicaid programs covered GLP-1s for obesity under fee-for-service as of January 2026, and several states have narrowed or ended coverage since. Coverage for type 2 diabetes is more common and is separate from weight-management coverage.
GLP-1 telehealth options in New Mexico
If you do not have coverage, do not qualify under your plan’s criteria, or do not want to navigate prior authorization, a cash-pay telehealth program is one route to discuss. Transformation Health connects patients with independent, licensed providers who evaluate your health history through an online assessment and determine whether a GLP-1 program is medically appropriate. You do not need a diabetes diagnosis to be evaluated, and you do not need insurance.
Pricing is all-inclusive and covers medication, lab work, and provider care with no hidden fees. To see whether you qualify and compare program options, start with the GLP-1 weight loss program overview or check whether you qualify if you are not diabetic.
Who qualifies for GLP-1 weight management in New Mexico
You do not need a diabetes diagnosis to be considered for GLP-1 weight management. A licensed provider generally evaluates candidates with a body mass index (BMI) of 30 or higher, or 27 or higher when paired with a weight-related health condition such as high blood pressure, elevated cholesterol, or prediabetes. The provider reviews your full health history, current medications, and goals before deciding whether treatment is appropriate, so eligibility is always an individual determination rather than a guarantee.
A large share of people seeking GLP-1 weight management in New Mexico are women between roughly 35 and 50 who are navigating weight changes tied to perimenopause, when shifting hormones can make weight harder to manage even when nothing else has changed. If that describes you, the appetite and metabolic effects of GLP-1 medications are one option worth discussing with a provider. You can read more about whether GLP-1 medications are appropriate if you are not diabetic and how GLP-1 medications work.
What an all-inclusive GLP-1 program includes
Out-of-pocket cost is the question most people ask after they learn their plan does not cover weight-management GLP-1s. A transparent telehealth program bundles the pieces into one monthly membership so there are no surprise charges:
- Medication prepared by a US-based, state-licensed compounding pharmacy
- Evaluation and ongoing care from an independent, licensed provider
- Lab work through national labs such as Quest or Labcorp
- Weight-management coaching and check-ins
- Shipping to your door, with no hidden fees and the ability to cancel anytime
Because compounded medications are not FDA-approved and are not the same as FDA-approved generic drugs, a provider will explain what that means for you before anything is prescribed.
How getting started works in New Mexico
The process is built around a medical evaluation, not a checkout. For someone in New Mexico, it typically looks like this:
- Complete a free online health assessment that covers your history, medications, and goals.
- An independent, licensed provider reviews your information and determines whether a GLP-1 program is medically appropriate. Not everyone qualifies.
- If appropriate, your prescription is sent to a licensed compounding pharmacy and your medication ships to you, with provider support and coaching throughout.
There is no obligation to continue, and the assessment itself is free. If a GLP-1 program is not the right fit for your situation, the provider will tell you. To begin, see the GLP-1 weight loss program overview or compare obesity and access data for other states on the GLP-1 by state page.
See If You Qualify in Under 5 Minutes
Our online assessment is reviewed by a U.S.-licensed physician. No insurance needed. Cancel anytime.
Get StartedData sources and methodology
- Adult obesity and physical inactivity: CDC Nutrition, Physical Activity, and Obesity, Behavioral Risk Factor Surveillance System. New Mexico figures are from the 2024 data release; the national comparison is 33.1% (2024). Obesity prevalence is the percentage of adults with a body mass index of 30 or higher, based on self-reported height and weight, so figures may differ from measured surveys such as NHANES. Physical inactivity is the share of adults reporting no leisure-time physical activity (2024).
- Medicaid coverage: KFF, Medicaid Coverage of and Spending on GLP-1s, as of January 2026. State Medicaid coverage of GLP-1 medications for weight loss changes frequently and is summarized here for general information only. Always confirm current benefits and prior-authorization rules directly with New Mexico Medicaid or your plan.
- Data current as of: 2024 CDC release. Page last updated: June 16, 2026.
Important: Compounded medications are not FDA-approved products. They are prepared by US-based, state-licensed compounding pharmacies and have not been independently evaluated by the FDA for safety, efficacy, or quality. Medicaid coverage information is general, changes frequently, and should be confirmed with your state program. All prescriptions require evaluation by an independent, licensed healthcare provider. Not all patients will qualify. Results vary by individual.